Rheumatoid Arthritis

Biosafety is the major concern in clinical translation of nanomedicine. As an intrinsic ingredient of human blood without immunogenicity and the emphasis on its successful clinical application in Abraxane, albumin has been considered as a promising material to produce nanoparticles for bioimaging and drug delivery.https://www.creative-biolabs.com/targeted-delivery/delivery-system-based-on-albumin.htm